Survival and functional outcomes in paediatric thalamic and thalamopeduncular low grade gliomas

. 2022 Jun ; 164 (6) : 1459-1472. [epub] 20220119

Jazyk angličtina Země Rakousko Médium print-electronic

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid35043265
Odkazy

PubMed 35043265
DOI 10.1007/s00701-021-05106-5
PII: 10.1007/s00701-021-05106-5
Knihovny.cz E-zdroje

BACKGROUND: Childhood thalamopeduncular gliomas arise at the interface of the thalamus and cerebral peduncle. The optimal treatment is total resection but not at the cost of neurological function. We present long-term clinical and oncological outcomes of maximal safe resection. METHODS: Retrospective review of prospectively collected data: demography, symptomatology, imaging, extent of resection, surgical complications, histology, functional and oncological outcome. RESULTS: During 16-year period (2005-2020), 21 patients were treated at our institution. These were 13 girls and 8 boys (mean age 7.6 years). Presentation included progressive hemiparesis in 9 patients, raised intracranial pressure in 9 patients and cerebellar symptomatology in 3 patients. The tumour was confined to the thalamus in 6 cases. Extent of resection was judged on postoperative imaging as total (6), near-total (6) and less extensive (9). Surgical complications included progression of baseline neurological status in 6 patients, and 5 of these gradually improved to preoperative status. All tumours were classified as low-grade gliomas. Disease progression was observed in 9 patients (median progression-free survival 7.3 years). At last follow-up (median 6.1 years), all patients were alive, median Lansky score of 90. Seven patients were without evidence of disease, 6 had stable disease, 7 stable following progression and 1 had progressive disease managed expectantly. CONCLUSION: Paediatric patients with low-grade thalamopeduncular gliomas have excellent long-term functional and oncological outcomes when gross total resection is not achievable. Surgery should aim at total resection; however, neurological function should not be endangered due to excellent chance for long-term survival.

Zobrazit více v PubMed

Bandopadhayay P, Bergthold G, London WB, Goumnerova LC, Morales La Madrid A, Marcus KJ, Guo D, Ullrich NJ, Robison NJ, Chi SN et al (2014) Long-term outcome of 4,040 children diagnosed with pediatric low-grade gliomas: an analysis of the Surveillance Epidemiology and End Results (SEER) database. Pediatr Blood Cancer 61:1173–1179. https://doi.org/10.1002/pbc.24958 PubMed DOI PMC

Baroncini M, Vinchon M, Minéo JF, Pichon F, Francke JP, Dhellemmes P (2007) Surgical resection of thalamic tumors in children: approaches and clinical results. Childs Nerv Syst 23:753–760. https://doi.org/10.1007/s00381-007-0299-4 PubMed DOI

Bilginer B, Narin F, Işıkay I, Oguz KK, Söylemezoglu F, Akalan N (2014) Thalamic tumors in children. Childs Nerv Syst 30:1493–1498. https://doi.org/10.1007/s00381-014-2420-9 PubMed DOI

Broadway SJ, Ogg RJ, Scoggins MA, Sanford R, Patay Z, Boop FA (2011) Surgical management of tumors producing the thalamopeduncular syndrome of childhood. J Neurosurg Pediatr 7:589–595. https://doi.org/10.3171/2011.4.Peds119 PubMed DOI PMC

Celtikci E, Celtikci P, Fernandes-Cabral DT, Ucar M, Fernandez-Miranda JC, Borcek AO (2017) High-definition fiber tractography in evaluation and surgical planning of thalamopeduncular pilocytic astrocytomas in pediatric population: case series and review of literature. World Neurosurg 98:463–469. https://doi.org/10.1016/j.wneu.2016.11.061 PubMed DOI

Cheek WR, Taveras JM (1966) Thalamic tumors. J Neurosurg 24:505–513. https://doi.org/10.3171/jns.1966.24.2.0505 PubMed DOI

Cinalli G, Aguirre DT, Mirone G, Ruggiero C, Cascone D, Quaglietta L, Aliberti F, Santi SD, Buonocore MC, Nastro A et al (2018) Surgical treatment of thalamic tumors in children. J Neurosurg Pediatr 21:247–257. https://doi.org/10.3171/2017.7.Peds16463 PubMed DOI

Cuccia V, Monges J (1997) Thalamic tumors in children. Childs Nerv Syst 13: 514–520; discussion 521 https://doi.org/10.1007/s003810050128

Douw L, Klein M, Fagel SS, van den Heuvel J, Taphoorn MJ, Aaronson NK, Postma TJ, Vandertop WP, Mooij JJ, Boerman RH et al (2009) Cognitive and radiological effects of radiotherapy in patients with low-grade glioma: long-term follow-up. Lancet Neurol 8:810–818. https://doi.org/10.1016/s1474-4422(09)70204-2 PubMed DOI

Fangusaro J, Witt O, Hernáiz Driever P, Bag AK, de Blank P, Kadom N, Kilburn L, Lober RM, Robison NJ, Fisher MJ et al (2020) Response assessment in paediatric low-grade glioma: recommendations from the Response Assessment in Pediatric Neuro-Oncology (RAPNO) working group. Lancet Oncol 21:e305–e316. https://doi.org/10.1016/s1470-2045(20)30064-4 PubMed DOI

Fedorov A, Beichel R, Kalpathy-Cramer J, Finet J, Fillion-Robin JC, Pujol S, Bauer C, Jennings D, Fennessy F, Sonka M et al (2012) 3D Slicer as an image computing platform for the Quantitative Imaging Network. Magn Reson Imaging 30:1323–1341. https://doi.org/10.1016/j.mri.2012.05.001 PubMed DOI PMC

Ferroli P, Broggi M, Schiavolin S, Acerbi F, Bettamio V, Caldiroli D, Cusin A, La Corte E, Leonardi M, Raggi A et al (2015) Predicting functional impairment in brain tumor surgery: the Big Five and the Milan Complexity Scale. Neurosurg Focus 39:E14. https://doi.org/10.3171/2015.9.Focus15339 PubMed DOI

Gunny RS, Hayward RD, Phipps KP, Harding BN, Saunders DE (2005) Spontaneous regression of residual low-grade cerebellar pilocytic astrocytomas in children. Pediatr Radiol 35:1086–1091. https://doi.org/10.1007/s00247-005-1546-z PubMed DOI

Hirose G, Lombroso CT, Eisenberg H (1975) Thalamic tumors in childhood. Clinical, laboratory, and therapeutic considerations. Arch Neurol 32:740–744. https://doi.org/10.1001/archneur.1975.00490530062005 PubMed DOI

Hoffman HJ, Soloniuk DS, Humphreys RP, Drake JM, Becker LE, De Lima BO, Piatt JH Jr (1993) Management and outcome of low-grade astrocytomas of the midline in children: a retrospective review. Neurosurgery 33:964–971. https://doi.org/10.1227/00006123-199312000-00002 PubMed DOI

Johnson DR, Brown PD, Galanis E, Hammack JE (2012) Pilocytic astrocytoma survival in adults: analysis of the Surveillance, Epidemiology, and End Results Program of the National Cancer Institute. J Neurooncol 108:187–193. https://doi.org/10.1007/s11060-012-0829-0 PubMed DOI

Karschnia P, Vogelbaum MA, van den Bent M, Cahill DP, Bello L, Narita Y, Berger MS, Weller M, Tonn JC (2021) Evidence-based recommendations on categories for extent of resection in diffuse glioma. Eur J Cancer 149:23–33. https://doi.org/10.1016/j.ejca.2021.03.002 PubMed DOI

Lansky SB, List MA, Lansky LL, Ritter-Sterr C, Miller DR (1987) The measurement of performance in childhood cancer patients. Cancer 60:1651–1656. https://doi.org/10.1002/1097-0142(19871001)60:7%3c1651::aid-cncr2820600738%3e3.0.co;2-j PubMed DOI

Lassaletta A, Zapotocky M, Mistry M, Ramaswamy V, Honnorat M, Krishnatry R, Guerreiro Stucklin A, Zhukova N, Arnoldo A, Ryall S et al (2017) Therapeutic and prognostic implications of BRAF V600E in pediatric low-grade gliomas. J Clin Oncol 35:2934–2941. https://doi.org/10.1200/jco.2016.71.8726 PubMed DOI PMC

Lee RP, Foster KA, Lillard JC, Klimo P Jr, Ellison DW, Orr B, Boop FA (2017) Surgical and molecular considerations in the treatment of pediatric thalamopeduncular tumors. J Neurosurg Pediatr 20:247–255. https://doi.org/10.3171/2017.4.Peds16668 PubMed DOI PMC

Mistry M, Zhukova N, Merico D, Rakopoulos P, Krishnatry R, Shago M, Stavropoulos J, Alon N, Pole JD, Ray PN et al (2015) BRAF mutation and CDKN2A deletion define a clinically distinct subgroup of childhood secondary high-grade glioma. J Clin Oncol 33:1015–1022. https://doi.org/10.1200/jco.2014.58.3922 PubMed DOI PMC

Moshel YA, Link MJ, Kelly PJ (2007) Stereotactic volumetric resection of thalamic pilocytic astrocytomas. Neurosurgery 61: 66–75; discussion 75 Doi https://doi.org/10.1227/01.neu.0000279725.13521.a3

Nobre L, Zapotocky M, Ramaswamy V, Ryall S, Bennett J, Alderete D, Balaguer Guill J, Baroni L, Bartels U, Bavle Aet al (2020) Outcomes of BRAF V600E pediatric gliomas treated with targeted BRAF inhibition. JCO Precis Oncol 4 https://doi.org/10.1200/po.19.00298

Ozek MM, Türe U (2002) Surgical approach to thalamic tumors. Childs Nerv Syst 18:450–456. https://doi.org/10.1007/s00381-002-0608-x PubMed DOI

Puget S, Crimmins DW, Garnett MR, Grill J, Oliveira R, Boddaert N, Wray A, Lelouch-Tubiana A, Roujeau T, Di Rocco F et al (2007) Thalamic tumors in children: a reappraisal. J Neurosurg 106:354–362. https://doi.org/10.3171/ped.2007.106.5.354 PubMed DOI

Ramaswamy V, Hielscher T, Mack SC, Lassaletta A, Lin T, Pajtler KW, Jones DT, Luu B, Cavalli FM, Aldape K et al (2016) Therapeutic impact of cytoreductive surgery and irradiation of posterior fossa ependymoma in the molecular era: a retrospective multicohort analysis. J Clin Oncol 34:2468–2477. https://doi.org/10.1200/jco.2015.65.7825 PubMed DOI PMC

Rangel-Castilla L, Spetzler RF (2015) The 6 thalamic regions: surgical approaches to thalamic cavernous malformations, operative results, and clinical outcomes. J Neurosurg 123:676–685. https://doi.org/10.3171/2014.11.Jns14381 PubMed DOI

Rees J, Watt H, Jäger HR, Benton C, Tozer D, Tofts P, Waldman A (2009) Volumes and growth rates of untreated adult low-grade gliomas indicate risk of early malignant transformation. Eur J Radiol 72:54–64. https://doi.org/10.1016/j.ejrad.2008.06.013 PubMed DOI

Renedo D, Ferraro F, Johnson AR, Argañaraz R, Giovannini S, Zabala JP, Zemma E, Mantese B (2021) Thalamic tumors in children: case series from our institution and literature review. Childs Nerv Syst 37:457–463. https://doi.org/10.1007/s00381-020-04830-0 PubMed DOI

Renzi S, Michaeli O, Ramaswamy V, Huang A, Stephens D, Maguire B, Tabori U, Bouffet E, Bartels U (2020) Causes of death in pediatric neuro-oncology: the sickkids experience from 2000 to 2017. J Neurooncol 149:181–189. https://doi.org/10.1007/s11060-020-03590-w PubMed DOI

Rozen WM, Joseph S, Lo PA (2008) Spontaneous regression of low-grade gliomas in pediatric patients without neurofibromatosis. Pediatr Neurosurg 44:324–328. https://doi.org/10.1159/000134925 PubMed DOI

Ryall S, Zapotocky M, Fukuoka K, Nobre L, Guerreiro Stucklin A, Bennett J, Siddaway R, Li C, Pajovic S, Arnoldo A et al (2020) Integrated molecular and clinical analysis of 1,000 pediatric low-grade gliomas. Cancer Cell 37:569-583.e565. https://doi.org/10.1016/j.ccell.2020.03.011 PubMed DOI PMC

Ryu HH, Jung TY, Lee GJ, Lee KH, Jung SH, Jung S, Baek HJ (2015) Differences in the clinical courses of pediatric and adult pilocytic astrocytomas with progression: a single-institution study. Childs Nerv Syst 31:2063–2069. https://doi.org/10.1007/s00381-015-2887-z PubMed DOI

Serra C, Türe H, Yaltırık CK, Harput MV, Türe U (2020) Microneurosurgical removal of thalamic lesions: surgical results and considerations from a large, single-surgeon consecutive series. J Neurosurg: 1-11 https://doi.org/10.3171/2020.6.Jns20524

Smrčka M, Brichtová E, Mackerle Z, Juráň V, Přibáň V (2015) Surgical approaches to thalamic tumors. Cesk Slov Neurol N 78:172–180

Steinbok P, Gopalakrishnan CV, Hengel AR, Vitali AM, Poskitt K, Hawkins C, Drake J, Lamberti-Pasculli M, Ajani O, Hader W et al (2016) Pediatric thalamic tumors in the MRI era: a Canadian perspective. Childs Nerv Syst 32:269–280. https://doi.org/10.1007/s00381-015-2968-z PubMed DOI

Tian Y, Rich BE, Vena N, Craig JM, Macconaill LE, Rajaram V, Goldman S, Taha H, Mahmoud M, Ozek M et al (2011) Detection of KIAA1549-BRAF fusion transcripts in formalin-fixed paraffin-embedded pediatric low-grade gliomas. J Mol Diagn 13:669–677. https://doi.org/10.1016/j.jmoldx.2011.07.002 PubMed DOI PMC

Upadhyaya SA, Koschmann C, Muraszko K, Venneti S, Garton HJ, Hamstra DA, Maher CO, Betz BL, Brown NA, Wahl D et al (2017) Brainstem low-grade gliomas in children-excellent outcomes with multimodality therapy. J Child Neurol 32:194–203. https://doi.org/10.1177/0883073816675547 PubMed DOI

Villarejo F, Amaya C, Pérez Díaz C, Pascual A, Alvarez Sastre C, Goyenechea F (1994) Radical surgery of thalamic tumors in children. Childs Nerv Syst 10:111–114. https://doi.org/10.1007/bf00302774 PubMed DOI

Wisoff JH, Sanford RA, Heier LA, Sposto R, Burger PC, Yates AJ, Holmes EJ, Kun LE (2011) Primary neurosurgery for pediatric low-grade gliomas: a prospective multi-institutional study from the Children’s Oncology Group. Neurosurgery 68: 1548–1554; discussion 1554–1545 Doi https://doi.org/10.1227/NEU.0b013e318214a66e

Youland RS, Brown PD, Giannini C, Parney IF, Uhm JH, Laack NN (2013) Adult low-grade glioma: 19-year experience at a single institution. Am J Clin Oncol 36:612–619. https://doi.org/10.1097/COC.0b013e31825d580a PubMed DOI PMC

Zapotocky M, Beera K, Adamski J, Laperierre N, Guger S, Janzen L, Lassaletta A, Figueiredo Nobre L, Bartels U, Tabori U et al (2019) Survival and functional outcomes of molecularly defined childhood posterior fossa ependymoma: cure at a cost. Cancer 125:1867–1876. https://doi.org/10.1002/cncr.31995 PubMed DOI

Zattra CM, Broggi M, Schiavolin S, Schiariti M, Acerbi F, Esposito S, de Laurentis C, Broggi G, Ferroli P (2021) Surgical outcome and indicators of postoperative worsening in intra-axial thalamic and posterior fossa pediatric tumors: preliminary results from a single tertiary referral center cohort. Interdisciplinary Neurosurgery 24:101054. https://doi.org/10.1016/j.inat.2020.101054 DOI

Zhang J, Wu G, Miller CP, Tatevossian RG, Dalton JD, Tang B, Orisme W, Punchihewa C, Parker M, Qaddoumi I et al (2013) Whole-genome sequencing identifies genetic alterations in pediatric low-grade gliomas. Nat Genet 45:602–612. https://doi.org/10.1038/ng.2611 PubMed DOI PMC

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...